CIBC Asset Management’s Halozyme HALO Stock Holding History

CIBC Asset Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Sell	3,650 -316	-8%	-$21.5K	﹤0.01%	1082
2026 Q1	$256K	Hold	3,966	–	–	﹤0.01%	1074
2025 Q4	$267K	Hold	3,966	–	–	﹤0.01%	1042
2025 Q3	$291K	Hold	3,966	–	–	﹤0.01%	942
2025 Q2	$206K	Hold	3,966	–	–	﹤0.01%	1106
2025 Q1	$253K	Buy	+3,966	New	+$230K	﹤0.01%	946
2024 Q4	–	Sell	-3,691	Closed	-$211K	–	1252
2024 Q3	$211K	Buy	+3,691	New	+$212K	﹤0.01%	1083
2023 Q1	–	Sell	-3,641	Closed	-$207K	–	1097
2022 Q4	$207K	Sell	3,641 -2,019	-36%	-$103K	﹤0.01%	930
2022 Q3	$224K	Hold	5,660	–	–	﹤0.01%	1024
2022 Q2	$249K	Sell	5,660 -414	-7%	-$17.9K	﹤0.01%	977
2022 Q1	$242K	Hold	6,074	–	–	﹤0.01%	1197
2021 Q4	$244K	Buy	6,074 +285	+5%	+$10.6K	﹤0.01%	1222
2021 Q3	$235K	Buy	5,789 +758	+15%	+$31.7K	﹤0.01%	1216
2021 Q2	$228K	Hold	5,031	–	–	﹤0.01%	1192
2021 Q1	$210K	Sell	5,031 -716	-12%	-$32.7K	﹤0.01%	1218
2020 Q4	$245K	Buy	+5,747	New	+$207K	﹤0.01%	1008

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CIBC Asset Management's HALO Position: Q2 2026 in Review

CIBC Asset Management reduced its Halozyme (HALO) stake by 8% in Q2 2026, selling an estimated $21.5K and leaving 3,650 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

CIBC Asset Management first reported a position in HALO in Q4 2020 and has held it in 16 quarters since. The position peaked at $291K in Q3 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

CIBC Asset Management held 3,650 shares of Halozyme worth $286K as of Q2 2026.
CIBC Asset Management sold 316 Halozyme shares in Q2 2026, an estimated $21.5K.
Halozyme made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1082 holding.
CIBC Asset Management first reported a position in Halozyme in Q4 2020 and has held it in 16 quarters since.
CIBC Asset Management's Halozyme position peaked at $291K in Q3 2025.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.